Werewolf Therapeutics (HOWL) Competitors $1.18 -0.01 (-0.84%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$1.16 -0.01 (-1.27%) As of 09:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HOWL vs. CRGX, YMAB, NLTX, EDIT, ELDN, MDWD, AVTE, IPHA, SXTC, and ENGNShould you be buying Werewolf Therapeutics stock or one of its competitors? The main competitors of Werewolf Therapeutics include CARGO Therapeutics (CRGX), Y-mAbs Therapeutics (YMAB), Neoleukin Therapeutics (NLTX), Editas Medicine (EDIT), Eledon Pharmaceuticals (ELDN), MediWound (MDWD), Aerovate Therapeutics (AVTE), Innate Pharma (IPHA), China SXT Pharmaceuticals (SXTC), and enGene (ENGN). These companies are all part of the "pharmaceutical products" industry. Werewolf Therapeutics vs. Its Competitors CARGO Therapeutics Y-mAbs Therapeutics Neoleukin Therapeutics Editas Medicine Eledon Pharmaceuticals MediWound Aerovate Therapeutics Innate Pharma China SXT Pharmaceuticals enGene CARGO Therapeutics (NASDAQ:CRGX) and Werewolf Therapeutics (NASDAQ:HOWL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership. Which has more volatility and risk, CRGX or HOWL? CARGO Therapeutics has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, Werewolf Therapeutics has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Which has stronger earnings and valuation, CRGX or HOWL? Werewolf Therapeutics has higher revenue and earnings than CARGO Therapeutics. CARGO Therapeutics is trading at a lower price-to-earnings ratio than Werewolf Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.97Werewolf Therapeutics$1.14M46.33-$70.51M-$1.67-0.71 Do institutionals & insiders hold more shares of CRGX or HOWL? 93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 64.8% of Werewolf Therapeutics shares are owned by institutional investors. 2.9% of CARGO Therapeutics shares are owned by insiders. Comparatively, 23.6% of Werewolf Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is CRGX or HOWL more profitable? CARGO Therapeutics' return on equity of -45.93% beat Werewolf Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CARGO TherapeuticsN/A -45.93% -39.58% Werewolf Therapeutics N/A -89.37%-54.87% Do analysts recommend CRGX or HOWL? CARGO Therapeutics presently has a consensus price target of $15.40, suggesting a potential upside of 243.75%. Werewolf Therapeutics has a consensus price target of $8.33, suggesting a potential upside of 606.21%. Given Werewolf Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Werewolf Therapeutics is more favorable than CARGO Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86Werewolf Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor CRGX or HOWL? In the previous week, CARGO Therapeutics had 4 more articles in the media than Werewolf Therapeutics. MarketBeat recorded 5 mentions for CARGO Therapeutics and 1 mentions for Werewolf Therapeutics. CARGO Therapeutics' average media sentiment score of 1.13 beat Werewolf Therapeutics' score of 0.37 indicating that CARGO Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CARGO Therapeutics 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Werewolf Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryWerewolf Therapeutics beats CARGO Therapeutics on 9 of the 14 factors compared between the two stocks. Get Werewolf Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOWL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOWL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOWL vs. The Competition Export to ExcelMetricWerewolf TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$53.40M$2.98B$5.42B$9.56BDividend YieldN/A2.46%3.99%4.14%P/E Ratio-0.7117.9729.9025.14Price / Sales46.33177.57372.1776.15Price / CashN/A41.8335.9458.58Price / Book0.727.238.105.59Net Income-$70.51M-$54.43M$3.26B$265.48M7 Day Performance1.72%0.22%0.65%1.22%1 Month Performance11.32%5.59%2.43%0.39%1 Year Performance-36.22%9.98%27.70%23.47% Werewolf Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOWLWerewolf Therapeutics3.8055 of 5 stars$1.18-0.8%$8.33+606.2%-31.0%$53.40M$1.14M-0.7140News CoverageUpcoming EarningsCRGXCARGO Therapeutics2.5059 of 5 stars$4.48-0.2%$15.40+243.8%-67.6%$207.03MN/A-0.97116Positive NewsUpcoming EarningsYMABY-mAbs Therapeutics2.2872 of 5 stars$4.19-7.5%$15.60+272.3%-22.5%$205.13M$87.68M-6.55150Trending NewsUpcoming EarningsAnalyst DowngradeHigh Trading VolumeNLTXNeoleukin TherapeuticsN/A$21.78+0.0%N/A-43.8%$204.69MN/A-7.0090High Trading VolumeEDITEditas Medicine4.24 of 5 stars$2.56+4.9%$4.70+83.6%-39.4%$204.26M$32.31M-0.84230ELDNEledon Pharmaceuticals1.6755 of 5 stars$3.25-3.8%$10.00+207.7%+5.4%$202.40MN/A-1.5510Gap DownMDWDMediWound2.1759 of 5 stars$18.37-0.9%$32.25+75.6%+14.9%$200.27M$19.21M-8.7980Upcoming EarningsHigh Trading VolumeAVTEAerovate TherapeuticsN/A$6.89-4.2%N/A-86.6%$199.71MN/A-2.3020Upcoming EarningsHigh Trading VolumeIPHAInnate Pharma2.9277 of 5 stars$2.11-1.9%$11.00+421.3%+0.5%$198.20M$21.77M0.00220News CoverageSXTCChina SXT Pharmaceuticals0.8657 of 5 stars$1.58-7.1%N/A-79.4%$197.25M$1.74M0.0090Gap UpENGNenGene3.3111 of 5 stars$3.82-0.3%$23.29+509.6%-49.2%$195.73MN/A-2.3231High Trading Volume Related Companies and Tools Related Companies CARGO Therapeutics Alternatives Y-mAbs Therapeutics Alternatives Neoleukin Therapeutics Alternatives Editas Medicine Alternatives Eledon Pharmaceuticals Alternatives MediWound Alternatives Aerovate Therapeutics Alternatives Innate Pharma Alternatives China SXT Pharmaceuticals Alternatives enGene Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOWL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
